Replicel Life Sciences Inc
XTSX:RP
Balance Sheet
Balance Sheet Decomposition
Replicel Life Sciences Inc
Replicel Life Sciences Inc
Balance Sheet
Replicel Life Sciences Inc
| Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
-12%
|
0
-11%
|
|
| Liabilities | ||||
| Accounts Payable |
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-2%
|
0
+14%
|
|
| Equity | ||||
| Common Stock |
1
|
1
|
1
|
|
| Retained Earnings |
0
|
0
|
0
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
-12%
|
0
-11%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
-12%
|
0
-11%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
8
|
8
|
8
|
|